Thursday, January 22, 2026
HomeNews

News

U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Repotrectinib for the Treatment of Patients with Locally Advanced or...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for repotrectinib, a next-generation tyrosine...

Castle Biosciences Celebrates Skin Cancer Awareness Month

Castle Biosciences, Inc, a company improving health through innovative tests that guide patient care, recognizes the importance of Skin Cancer Awareness Month and is...

HeartBeam Enters into Strategic Alliance Agreement with Samsung

HeartBeam, Inc, a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today...

Anton/Bauer Unleashes Salt-E Dog: The Future of Sustainable Film & TV Production – Powered by Sodium

Anton/Bauer a leading manufacturer of mobile power solutions for broadcast and cinematic equipment and a Videndum brand, has announced the launch of Salt-E Dog, a...

GE HealthCare Receives FDA Clearance of a New Deep Learning Solution for Enhanced Image Quality in PET/CT, Advancing its Leadership Position in AI

GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning-based image processing software included in GE HealthCare’s growing...
0FansLike
0FollowersFollow
spot_img

Hot Topics